SNOA
Sonoma Pharmaceuticals Inc
NASDAQ: SNOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.10
+3.77% today
Updated 2026-04-30
Market cap
$4.98M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-1.95
Dividend yield
—
52W range
$1 – $7
Volume
0.2M
WallStSmart proprietary scores
44
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+5.0
Quality
C+2.0
Profitability
F7.0
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$12.00
+990.91%
12-Month target
—
—
Intrinsic (DCF)
$4.11
Margin of safety
+33.09%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 22.00% QoQ
+ 33.09% below intrinsic value
Risks
- Thin margins at -19.00%
- Negative free cash flow $-811000.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $12.63M | $13.27M | $12.73M | $14.29M | $17.72M |
| Net income | $-5.09M | $-5.15M | $-4.83M | $-3.46M | $-819000.00 |
| EPS | — | — | — | — | $-1.95 |
| Free cash flow | $-4.38M | $-6.42M | $-2.42M | $-168000.00 | $-811000.00 |
| Profit margin | -40.28% | -38.81% | -37.97% | -24.20% | -19.00% |
Peer comparison
Smart narrative
Sonoma Pharmaceuticals Inc trades at $1.10. Our Smart Value Score of 44/100 indicates the stock is fair. TTM revenue stands at $17.72M. with profit margins at -19.00%. Our DCF model estimates intrinsic value at $4.11.
Frequently asked questions
What is Sonoma Pharmaceuticals Inc's stock price?
Sonoma Pharmaceuticals Inc (SNOA) trades at $1.10.
Is Sonoma Pharmaceuticals Inc overvalued?
Smart Value Score 44/100 (Grade D, Sell). DCF value $4.11.
What is the price target of Sonoma Pharmaceuticals Inc (SNOA)?
The analyst target price is $12.00, representing +990.9% upside from the current price of $1.10.
What is the intrinsic value of Sonoma Pharmaceuticals Inc (SNOA)?
Based on our DCF model, intrinsic value is $4.11, a +33.1% margin of safety versus $1.10.
What is Sonoma Pharmaceuticals Inc's revenue?
TTM revenue is $17.72M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.28x
ROE-81.20%
Beta1.76
50D MA$2.38
200D MA$3.40
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—